| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=0.1uM, N-{[(3s,4s)-4-Benzylpyrrolidin-3-Yl]methyl}-4-Methoxy-3-(3-Methoxypropoxy)-N-(Propan-2-Yl)benzamide, Renin Inhibitors targeting REN (Novartis, 11518143) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/11518143 |
| Similar Terms | |
| Downloads & Tools |
3 genes differentially expressed following the BC-13-GC37_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| LGALS14 | lectin, galactoside-binding, soluble, 14 | 0.274902 |
| IL18 | interleukin 18 | 0.217311 |
| Symbol | Name | Standardized Value |
|---|---|---|
| EFTUD2 | elongation factor Tu GTP binding domain containing 2 | -0.254556 |